Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | POLQ | O75417 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29427013 | 1.00 | IDO1 (0.57) | IDO1ALDH1A1KDM4EATMPOLB | |
| SCHEMBL376588 | 0.86 | IDO1 (0.46) | IDO1ALDH1A1KDM4EATMTDP1 | |
| SCHEMBL9568206 | 0.84 | IDO1 (0.44) | IDO1ALDH1A1KDM4EATMTDP1 | |
| SCHEMBL30252413 | 0.84 | IDO1 (0.52) | IDO1ALDH1A1KDM4EATMPOLB | |
| SCHEMBL3126891 | 0.84 | IDO1 (0.52) | IDO1ALDH1A1KDM4EATMPOLB | |
| SCHEMBL5359365 | 0.84 | IDO1 (0.42) | IDO1ALDH1A1KDM4EATMPOLB | |
| Ammonia Solution, Strong SCHEMBL27704287 | 0.82 | IDO1 (0.50) | IDO1ALDH1A1KDM4EATMPOLB | |
| SCHEMBL841044 | 0.82 | AKR1B1 (0.42) | IDO1ALDH1A1POLBTDP1L3MBTL1 | |
| SCHEMBL144963 | 0.82 | IDO1 (0.41) | IDO1ALDH1A1KDM4EATMPOLB | |
| SCHEMBL30806616 | 0.82 | AKR1B1 (0.42) | IDO1ALDH1A1POLBTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119101052-A | Matrine-triazole derivative and synthesis method thereof | 吉林医药学院 | 2024-12-10 | — | — | CN | claimed |
| CN-107089913-B | 2-substituted methyl rupestonic acid derivative and preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2020-10-09 | — | — | CN | claimed |
| CN-109810568-A | Inorganic nano material prints ink and its preparation method and application | TCL集团股份有限公司 | 2019-05-28 | — | — | CN | claimed |
| CN-109761911-A | A kind of preparation method of the polysubstituted pyrimidine derivative as Elagolix intermediate | 安徽诺全药业有限公司 | 2019-05-17 | — | — | CN | claimed |
| EP-2145895-B1 | Process for the manufacturing of glycochips | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2013-10-30 | — | — | EP | claimed |
| US-20100035353-A1 | PROCESS FOR THE MANUFACTURING OF GLYCOCHIPS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2010-02-11 | — | — | US | claimed |
| EP-2145895-A1 | Process for the manufacturing of glycochips | Commissariat à l'Energie Atomique (FR) | 2010-01-20 | — | — | EP | claimed |
| WO-2026107371-A2 | INDOLYL-PYRIDINONES AND RELATED COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12624041-B2 | Heterocyclic compound and use thereof | WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2026-05-12 | — | — | US | disclosed |
| US-12612361-B2 | Substituted pyrrolidones and piperidones as small molecule inhibitors of EZH2 and EED protein binding | NORTHWESTERN UNIVERSITY (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | SIRONAX LTD (KY) | 2026-03-19 | — | — | US | disclosed |
| US-12559490-B2 | Compositions and methods for modulating hair growth | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-24 | — | — | US | disclosed |
| US-12527774-B2 | Estrogen-related receptor alpha modulators | LEAD PHARMA HOLDING B.V. (NL) | 2026-01-20 | — | — | US | disclosed |
| US-4754050-A | COGNITION ACTIVATORS | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1988-06-28 | — | — | US | disclosed |
| US-4695573-A | COGNITION ACTIVATORS | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1987-09-22 | — | — | US | disclosed |
| EP-0179383-A2 | 9-Amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1986-04-30 | — | — | EP | disclosed |
| US-4579582-A | REDUCES THE GERMINATION OR EARLY GROWTH OF GRASSES | CHEVRON RESEARCH COMPANY (US) | 1986-04-01 | — | — | US | disclosed |
| US-4429119-A | PLANT GROWTH REGULATORS | CHEVRON RESEARCH COMPANY (US) | 1984-01-31 | — | — | US | disclosed |
| US-4209621-A | TRANQUILIZERS | AMERICAN CYANAMID COMPANY (US) | 1980-06-24 | — | — | US | disclosed |
| US-4077982-A | HERBICIDES | FMC CORPORATION (US) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | NAMPT, NNMT, SARM1 | IDO1 3108/4885ALDH1A1 2719/4885KDM4E 3382/4885 |
| US-12527774-B2 | Estrogen-related receptor alpha modulators | ESR2, ESRRA, ESRRB | IDO1 4538/4885ALDH1A1 696/4885KDM4E 350/4885 |
| US-12624041-B2 | Heterocyclic compound and use thereof | TRPC1, TRPC5, TRPC3 | IDO1 137/4885ALDH1A1 1028/4885KDM4E 4648/4885 |
| US-20100035353-A1 | PROCESS FOR THE MANUFACTURING OF GLYCOCHIPS | HGF, HGFAC, HDGF | IDO1 4161/4885ALDH1A1 2043/4885KDM4E 3944/4885 |
| US-12559490-B2 | Compositions and methods for modulating hair growth | PC, MTCH2, MPC2 | IDO1 645/4885ALDH1A1 605/4885KDM4E 836/4885 |
| US-12612361-B2 | Substituted pyrrolidones and piperidones as small molecule inhibitors of EZH2 and EED protein binding | EED, EZH2, EZH1 | IDO1 2321/4885ALDH1A1 1322/4885KDM4E 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.